PHARMACEUTICAL AND TECHNOLOGICAL EVALUATION OF THE SUBSTANCE AND TABLET MASS OF FLACOSIDE

Flacoside substance with the active ingredient "fellamurin" is an individual natural flavonoid glycoside isolated from the leaves of Amur cork tree, possessing antiviral, hepatoprotective, antioxidant, immunostimulating activity, from which in the 1980s VILAR employees developed the composition and technology of tablets, launched industrial production, which made it possible to use them in the treatment of chronic liver and biliary tract diseases of various origins. However, in the 1990s, the production of the drug was suspended, but the COVID-19 pandemic contributed to the ac-tualization of this development. The aim of the work is to determine the pharmaceutical and technological parameters of the substance and tablet mass of flacoside, to establish their compliance with the requirements of the State Pharmacopoeia of Russia, XV edition, and to identify ways to improve the technology for obtaining tablets to resume production of the drug. The technological parameters of the flacoside substance and the tablet mass obtained by wet granulation (in accordance with the previously developed Technological Regulations) were compared. The results of laser diffractometry, sieve analysis and optical microscopy showed that as a result of granu-lation, the particle size of the tablet mass increases significantly (from 0.02 mm to 1.3-1.5 mm). The bulk density before and after compaction, as well as the angle of natural repose, corresponded to those obtained in the 1980s, which confirms the pharmaceutical and technological identity of the flacoside substance obtained in 2022. A comprehensive pharmaceutical and technological assessment of powders based on 12 parameters, processed using the SeDeM expert system method, showed that the good compression index (GCI) of the flacoside substance, which is not suitable for direct pressing, increases by 1.30 (4.43 → 5.73) as a result of granulation, and the resulting tablet mass can be used for industrial pressing.

Authors

Institutions

Publication Details

Journal
Problems of Biological Medical and Pharmaceutical Chemistry
Published
2025-02-12
DOI
https://doi.org/10.29296/25877313-2025-02-02
Primary Topic
Phytochemistry and Biological Activities
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

PHARMACEUTICAL AND TECHNOLOGICAL EVALUATION OF THE SUBSTANCE AND TABLET MASS OF FLACOSIDE

О. П. Шейченко, Г.В. Адамов, N.A. Malysheva, A. S. Gulenkov et al.
Problems of Biological Medical and Pharmaceutical Chemistry
Phytochemistry and Biological Activities
article

PHARMACEUTICAL AND TECHNOLOGICAL EVALUATION OF THE SUBSTANCE AND TABLET MASS OF FLACOSIDE

О. П. Шейченко, Г.В. Адамов, N.A. Malysheva, A. S. Gulenkov, П.Г. Мизина, I.A. Radimich, K.E. Petrulenko
article en

Abstract

Flacoside substance with the active ingredient "fellamurin" is an individual natural flavonoid glycoside isolated from the leaves of Amur cork tree, possessing antiviral, hepatoprotective, antioxidant, immunostimulating activity, from which in the 1980s VILAR employees developed the composition and technology of tablets, launched industrial production, which made it possible to use them in the treatment of chronic liver and biliary tract diseases of various origins. However, in the 1990s, the production of the drug was suspended, but the COVID-19 pandemic contributed to the ac-tualization of this development. The aim of the work is to determine the pharmaceutical and technological parameters of the substance and tablet mass of flacoside, to establish their compliance with the requirements of the State Pharmacopoeia of Russia, XV edition, and to identify ways to improve the technology for obtaining tablets to resume production of the drug. The technological parameters of the flacoside substance and the tablet mass obtained by wet granulation (in accordance with the previously developed Technological Regulations) were compared. The results of laser diffractometry, sieve analysis and optical microscopy showed that as a result of granu-lation, the particle size of the tablet mass increases significantly (from 0.02 mm to 1.3-1.5 mm). The bulk density before and after compaction, as well as the angle of natural repose, corresponded to those obtained in the 1980s, which confirms the pharmaceutical and technological identity of the flacoside substance obtained in 2022. A comprehensive pharmaceutical and technological assessment of powders based on 12 parameters, processed using the SeDeM expert system method, showed that the good compression index (GCI) of the flacoside substance, which is not suitable for direct pressing, increases by 1.30 (4.43 → 5.73) as a result of granulation, and the resulting tablet mass can be used for industrial pressing.

Problems of Biological Medical and Pharmaceutical Chemistry
Sechenov University (RU), All-Russian Scientific Research Institute of Medicinal and Aromatic Plants (RU)
Openalex Percentile: Top 98%
Phytochemistry and Biological Activities
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.